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Wound healing: A paradigm for lumen
narrowing after arterial reconstruction
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Purpose: The intimal hyperplasia hypothesis that equates lumen narrowing after arterial
injury with intimal mass has recently been challenged. Evidence has emerged to suggest
that lumen narrowing is caused in large part by changes in artery wall geometry rather
than intimal mass per se. We have begun to explore this hypothesis in a unique nonhu-
man primate model of atherosclerosis.
Methods: Monkeys who were fed an atherogenic diet for 3 to 5 years underwent experi-
mental angioplasty of the left iliac artery. The contralateral iliac artery served as an
intraanimal control. Arteries were removed 2, 4, 7, 14, 28, or 112 days later for analy-
sis (6 or 13 per time point). Angioplasty dilated arteries by fracturing atheroma and
stretching or tearing the media. Cross-sections of injured arteries were analyzed for
expression of extracellular matrix components and cell surface integrins that are impor-
tant in wound healing. Antibodies, riboprobes, or histochemical stains specific for fib-
rin, hyaluronan, versican (chondroitin sulfate–containing proteoglycan), procollagen-I,
elastin, and the a2b1 and aVb3 integrins were used.
Results: A thin mural thrombus was seen at sites of denudation and plaque fracture (days
2 to 7). This provisional matrix was invaded by leukocytes (days 2 to 4) and a-actin–pos-
itive smooth muscle cells (SMCs; days 4 to 7). Thrombus was replaced by SMCs express-
ing hyaluronan and the associated versican proteoglycans (day 14). Versican was
expressed throughout the neointima as it enlarged (day 28), but expression later sub-
sided (day 112). Procollagen-I expression initially increased in the adventitia (day 4) and
then in the forming neointima (day 14). Procollagen-I expression was found to persist
within the adventitia and in the neointima in SMCs nearest the lumen (days 28 to 112).
Elastin staining was prominent within the mature neointima (day 112) but not at earli-
er time points. Integrin expression also increased within the injured artery wall. avb3
staining (fibrin[ogen] receptor) increased in the injured media (days 2 to 7) and was
then seen throughout the early neointima (day 7). Low level expression of aVb3 subse-
quently persisted within the forming neointima (day 28). a2b1 (collagen receptor)
expression increased in the neointima in SMCs nearest the lumen (day 28).
Conclusions: Lumen narrowing after angioplasty in this model of atherosclerosis is
caused largely by decreased artery wall diameter. The pattern of matrix and integrin
expression within the injured artery wall is in many ways analogous to that of healing
wounds. These observations suggest that tissue contraction may play a role in lumen
narrowing at sites of arterial reconstruction. Strategies to inhibit wound contraction
may prove effective in preventing restenosis. (J Vasc Surg 1998;27:96-108.)
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Recurrent lumen narrowing or “restenosis” after
arterial reconstruction remains a frequent and signif-
icant complication faced by patients who have symp-
tomatic atherosclerosis. Although an aging popula-
tion and improved technology continue to broaden
the application of both endovascular and surgical
interventions for arterial occlusive disease, effective
treatments to prevent restenosis remain elusive.
Until recently, restenosis has been viewed as the
consequence of intimal hyperplasia, the accumula-
tion of new cells and extracellular matrix (neointima)
at sites of vascular injury. Neointimal mass has been
equated with lumen encroachment. However, drugs
that are effective at preventing intimal hyperplasia in
animal models1,2 have consistently failed to prevent
restenosis in clinical trials.3,4 Therefore, other, less
well-defined mechanisms must play a predominant
role in restenosis. The clinical application of intravas-
cular ultrasound has allowed for serial measurement
of lumen, plaque, and wall size after intervention.
With this technique, it has been shown that vessel
wall diameter is a major determinant of lumen cal-
iber after angioplasty and that restenosis correlates
with decreased artery wall diameter.5 Our own data
in a nonhuman primate model of atherosclerosis
show that although experimental angioplasty causes
significant intimal hyperplasia, lumen area does not
correlate with intimal mass but rather with artery
size (r = 0.72; p < 0.001).6-8 These studies and oth-
ers suggest that artery wall narrowing leads to lumen
narrowing independent of the amount of intimal
thickening.9,10
Although the cellular and molecular basis of wall
narrowing after reconstruction is unknown, we sug-
gest that parallels can be drawn to wound healing.
Plaque fractures, dissections, and medial tears are
wounds. In cutaneous wounds, granulation tissue
forms within the coagulum as inflammatory cells
and activated fibroblasts migrate into this provision-
al matrix. The fibroblasts then proliferate and elabo-
rate a new collagen-rich extracellular matrix.
Fibroblasts are known to differentiate into wound
“myofibroblasts,” which transiently express a-actin
and can be stimulated to contract much like smooth
muscle cells (SMCs).11 Myofibroblasts reorganize
and contract the extracellular matrix via cell surface
integrins to reduce wound size.12-14 Similarly, tissue
contraction may lead to wall narrowing and resteno-
sis as the artery wall heals.
Here we extend our observations of the struc-
tural events after injury of atherosclerotic arteries6-8
and begin to define accompanying cellular and mol-
ecular changes that occur within the healing artery
wall. The patterns of cellular ingrowth, cell surface
integrin expression, and extracellular matrix elabora-
tion are consistent with a wound healing paradigm
JOURNAL OF VASCULAR SURGERY
Volume 27, Number 1 Geary et al. 97
within the artery wall. Further consideration of
mechanisms of wound contraction may lead to
improved outcomes after vascular reconstruction.
METHODS
Animal model. Female cynomolgus monkeys
(Macaca fascicularis) involved in long-term studies
of atherosclerosis at the Comparative Medicine
Clinical Research Center of the Bowman Gray
School of Medicine underwent experimental iliac
artery angioplasty. Animals were first ovariectomized
to induce a postmenopausal state and were fed an
atherogenic diet for 3 to 5 years to establish complex
atherosclerotic lesions.15 Experimental angioplasty
was then performed of the left common iliac artery
as previously described using a 3F Fogarty catheter
inflated and retrieved under tension three times.6
The right common iliac artery served as an unin-
jured control vessel in each animal.
The animals were then killed 2, 4, 7, 14, 28, or
120 days after angioplasty (six each at 2, 4, 7, 14,
and 120 days; 13 at 28 days). Animals were sedated
with ketamine (15 mg/kg by intramuscular injec-
tion) and butorphanol (0.05 mg/kg by intramuscu-
lar injection), and were given heparin (300 U/kg by
intravenous injection). Deep anesthesia was then
achieved with pentobarbital (100 mg/kg by intra-
venous injection), and the distal abdominal aorta
was cannulated. Iliac arteries were perfused in situ at
physiologic pressure with lactated Ringer’s until
rinsed clear of blood. Half of the animals at each
time-point then had both iliac arteries removed
fresh, and rings cut and frozen into OCT for sec-
tioning, with adjacent rings immersed in methyl
Carnoy’s fixative or 10% formalin for paraffin
embedding. The other half were perfusion-fixed
with 10% formalin at 100 mm Hg, and the distal
aorta, iliac, and femoral arteries were removed en
bloc and placed into fresh formalin overnight before
paraffin embedding.
All animal care and procedures were performed
at the Comparative Medicine Clinical Research
Center of The Bowman Gray School of Medicine in
accordance with state and federal laws. Animal pro-
tocols were preapproved by the Bowman Gray
Animal Care and Use Committee and conformed to
guidelines set forth by the American Association for
Accreditation of Laboratory Animal Care and by the
National Institutes of Health publication No. 86-23,
Guide for the Care and Use of Laboratory Animals.
Histologic examination. Perfusion-fixed com-
mon iliac arteries were divided into five adjacent
rings for paraffin embedding. Five micrometer thick
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sections were then cut from each block and stained
with Verhoeff–van Gieson stain (VVG) for cross-sec-
tional morphometry as reported previously.6-8
Sections were also cut and stained from each of the
frozen and immersion-fixed iliac artery rings.
Sections were studied by light microscopy to charac-
terize features associated with injury and healing of
the vessel wall at each time point after angioplasty
(e.g., plaque fracture, medial disruption, thrombus,
intimal hyperplasia, and adventitial changes).
Immunohistochemical analysis. Immuno-
histochemical analysis was performed to determine
the cellular composition and pattern of expression of
various extracellular matrix molecules and cell surface
integrins after experimental iliac artery angioplasty.
Cross-sections from paraffin-embedded injured and
uninjured iliac arteries were deparaffinized in xylenes,
rehydrated in graded alcohols, and immunostained as
previously described.6,16 For cell-type identification,
antibodies specific for SMC a-actin (1:250 dilution,
Boehringer), endothelial cell von Willebrand Factor
(vWF; 1:500, Dako), and macrophage CD68 antigen
(1:1000, Dako) were applied. For extracellular
matrix, the following antibodies were used: type-I
procollagen (1:10, Developmental Studies
Hybridoma Bank, University of Iowa), chondroitin-
6 sulfate proteoglycans (versican, 1:500, clone 3B3,
Dr. Bruce Caterson),17 and fibrin (1:100, American
Diagnostica). Antibodies directed against the avb3
integrin dimer (1:200, clone LM609, Chemicon)18
and the a2 integrin subunit (1:100, clone P1E6,
Gibco) were applied to frozen sections postfixed in
acetone. Primary antibodies were localized with
appropriate biotinylated secondary antibodies and
tertiary avidin-biotin-complex staining (Vector
Laboratories). Control slides were stained with
appropriate nonimmune immunoglobulin G in place
of the primary antibody or with antibody preincu-
Fig. 1. Composite photomicrograph of structural changes within the healing artery wall at day
4 (A, B, G), day 7 (C, D), day 14 (E, F), and day 28 (H, I, J, K) after experimental angio-
plasty. Angioplasty fractured preexisting plaque (arrowhead) and media, with a thin mural
thrombus forming at sites of injury (A, C; VVG stain). This provisional matrix was invaded by
leukocytes early after injury (B; monocyte CD68 stain) and later by SMCs (D; a-actin stain).
Cell proliferation was prominent at day 4 and later subsided (G; anti-BrdU stain).
Subsequently, neointima (n) filled in plaque (p) fracture sites (arrows) overlying the media (m)
and replaced the thrombus (E, VVG stain; and F, a-actin stain). Neointima continued to
thicken to day 28 (H; VVG stain) by accumulating SMCs and matrix (I; a-actin stain). When
compared with the uninjured iliac artery from the same animal (J; VVG stain), the injured
adventitia (a, arrows) had thickened and fibrosed by day 28 (K; VVG stain). Original magni-
fication: A, B, C, D, E, F, J, and K, ´200; G, ´40; and H and I, ´100.
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bated with a fivefold molar excess of purified antigen.
Hyaluronan was localized using a biotinylated
hyaluronan-binding protein (1:20 dilution, Dr.
Charles Underhill) and the avidin-biotin complex
reaction as previously described.19 Elastin was local-
ized histochemically with an orcein stain (1%
[wt/vol] in 70% acid alcohol, Harleco). Sections
were counter-stained with hematoxylin and exam-
ined by light microscopy.
In situ hybridization. In situ hybridization was
performed as previously described20 using human
cDNAs specific for type-I procollagen21 and the ver-
sican core protein.22 Briefly, formalin-fixed sections
were deparaffinized in xylene, rehydrated, washed,
and then incubated with proteinase K for 15 min-
utes at 37° C (1 mg/ml, Boehringer). Slides were
then incubated in hybridization buffer for 2 hours at
37° C (0.3 mol/L NaCl; 20 mmol/L Tris, pH 7.5;
5 mmol/L ethylenediamine tetraacetic acid, 1X
Denhardt solution, 10% dextran sulfate, 10 mmol/L
dithiothreitol, and 50% formamide). Sense and anti-
sense riboprobes were transcribed from each cDNA
using T3 and T7 polymerases (Promega) and
labeled with [35S]-UTP. Riboprobes were then
applied to tissue sections overnight in hybridization
buffer at 55° C. Slides were then washed and coated
with autoradiographic emulsion (Kodak, NTB2),
exposed for 1 and 2 weeks, developed (Kodak, D-
19), and counterstained with hematoxylin. Slides
were examined using dark field microscopy and dif-
ferential expression of each messenger RNA deter-
mined by comparison between sense and antisense-
labeled sections, as well as by contrasting the pattern
of labeling between various riboprobes.
RESULTS
Structural and histologic features of injury.
Experimental angioplasty typically fractured the pre-
existing atherosclerotic plaque and stretched or tore
the underlying media, creating a transmural artery
wall injury (Fig. 1). The subsequent healing
response involved all layers of the vessel wall, with
distinct responses among the preexisting atheroscle-
rotic intima, media, and the adventitia.
Thrombus formed a provisional fibrin-rich
matrix at sites of injury, which was initially popu-
lated by inflammatory cells (days 2 and 4; Fig. 1, A
and B) and subsequently by a-actin–positive cells
(day 7; Fig. 1, C and D). Our previous studies have
documented a brief but significant transmural wave
of cell replication early after injury (days 4 and 7;
Fig. 1, G).6 Thrombus was subsequently replaced
by neointima (day 14; Fig. 1, E through I) that
filled in the plaque and medial fracture sites. The
injured media repopulated rapidly with cells that
expressed a-actin at day 7 and day 14. Medial frac-
ture defects were filled in with tissue histologically
indistinct from, and contiguous with, the forming
neointima. The neointima thickened substantially
from day 14 to 28 as a-actin–expressing cells and
their extracellular matrix accumulated (Fig. 1, H
through I). Although the size and cellular compo-
sition of the neointima were similar at days 28 and
120, the composition of the extracellular matrix
Fig. 2. Composite photomicrograph of intimal fracture at day 4 after experimental angioplas-
ty. VVG stain (A) shows thrombus beneath intimal fracture (arrowhead). Hemorrhage is seen
within injured media (*). Immunohistochemical localization of platelet vWF (B) and fibrin (C)
are shown. Original magnification, ´200.
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differed strikingly between the two time points (see
below).
In contrast, adventitial healing was distinct from
the media and intima. Although hemorrhage was
occasionally seen within the injured adventitia,
thrombus was absent, so healing occurred within
preexisting adventitial connective tissue. The typical-
ly loose extracellular matrix of the adventitia became
dense and cellular when compared with uninjured
arteries. Histochemical staining (VVG) demonstrat-
ed accumulation of collagen-rich matrix within the
adventitia at days 14 and 28, whereas the neointima
stained pale, consistent with a proteoglycan-rich
matrix composition (Fig. 1, J and K). Although oth-
ers have described a clear early wave of a-actin
expression by cells in the adventitia of injured arter-
ies,23,24 this was not always seen in the present
model. At days 4 and 7, a-actin–expressing cells
(other than in microvessels) were occasionally found
within the injured adventitia, but this varied greatly
among injured iliac arteries. Beyond day 7, the cells
that populated the interstitium of the adventitia were
largely a-actin–negative fibroblasts and leukocytes.
Extracellular matrix elaboration after injury.
The provisional matrix of mural thrombus at sites of
injury was rich in fibrin (Fig. 2). As the neointima
formed, fibrin was trapped between the neointima
and the underlying wall components (Fig. 3). vWF
Fig. 3. Composite photomicrograph of neointima at day 28 stained with VVG (A) shows a
large neointima that is rich in vWF (B). C, Fibrin (arrowheads) becomes trapped within the
neointima (n) overlying the preexisting plaque (p) and media (m). Original magnification: A
and B, ´40; C, ´200.
Fig. 4. Composite photomicrograph of iliac arteries at various times after experimental angio-
plasty with histologic staining above (VVG) and respective dark field images of adjacent sections
labeled by in situ hybridization using a riboprobe for procollagen-I mRNA, below. Collagen
expression increased within 4 days in the adventitia and then in the early neointima. Late
expression is seen within the neointima near the lumen, and expression persists within the
adventitia. Original magnification: control, 4, and 14 days, ´200; 28 days, ´100.
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was also prominent in the platelet thrombus (Fig.
2), and significant vWF accumulated within the
extracellular matrix of the growing neointima at days
14 and 28 (Fig. 3). This pattern of staining was con-
firmed with other antibodies to vWF and was com-
pletely inhibited by preincubating the primary anti-
body with a fivefold molar excess of purified human
vWF (not shown). At day 120 vWF staining was
decreased within the neointima.
Procollagen-I expression increased in parallel
with proliferation early after angioplasty, and
immunohistochemical evaluation for procollagen-I
mirrored the pattern of mRNA expression (Fig. 4).
At day 4, when proliferation was maximal, expres-
sion could be seen throughout the injured adventi-
tia. As a-actin–positive cells began to appear at day
7 and day 14, expression was seen also throughout
the neointima. As the neointima thickened, procol-
lagen-I expression localized within the neointima
nearest to the lumen, a pattern that persisted at day
120. Adventitial procollagen-I expression was pre-
sent throughout the period of study.
Hyaluronan and versican were not prominent in
the uninjured atherosclerotic artery. These matrix
molecules are important components of healing
wounds,25,26 and their expression also increased sig-
nificantly in the injured artery wall. Hyaluronan
increased early within the injured media at day 4 and
Fig. 5. Composite photomicrograph of sections stained for hyaluronan. Staining was seen early
within the forming neointima and throughout the neointima as it matures. Control uninjured
iliac artery (A), plaque fracture at day 7 (B) and at day 14 (C). Staining persisted at day 28
(D) and day 120 (E). Preincubation of probe with hyaluronan completely blocked binding
(F). Original magnification, ´200.
Fig. 6. Composite photomicrograph of vessel cross-sections after experimental angioplasty
labeled with a riboprobe specific for versican core protein mRNA. Labeling increased within
the neointima at day 14 and persisted at day 28. Labeling had returned to baseline by day 120.
Original magnification, ´200.
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later localized to the neointima (Fig. 5). Hyaluronan
persisted in the early neointima from day 7 to days
14, 28, and 120. Versican was also expressed early
after injury. Both versican protein and mRNA were
present in a pattern similar to that for hyaluronan
from day 4 to 28. However, at day 120 versican core
protein mRNA was no longer expressed within the
healing artery wall (Fig. 6) and the protein staining
was diminished.
As proteoglycan staining diminished late after
injury, elastin fiber formation increased markedly
within the neointima, as shown with orcein staining
(Fig. 7). Elastin fibers were not seen within the early
neointima from days 7 to 28, but they increased sub-
stantially within the mature neointima at day 120.
Elastin fibers aligned tangential to the direction of
flow and were arranged loosely in layers parallel to
the internal elastic lamina.
Contractile integrin expression after injury.
Integrin expression was altered by injury. The a2(b1)
integrin, important in collagen-I contraction and
reorganization by fibroblasts and SMCs,11,27,28 was
absent in the uninjured iliac artery wall, even when
significant preexisting atherosclerotic plaque was
present. Staining increased transiently within the
neointima at day 28, where it localized to endothe-
lial cells and SMCs closest to the lumen (Fig. 8).
This pattern mirrored that of neointimal procolla-
gen-I expression at that time point. In contrast, the
avb3 integrin, important in cell-matrix interactions
with vitronectin, fibrin(ogen), denatured collagen,
osteopontin, and vWF,12,29 was present in athero-
sclerotic plaque and increased early after injury with-
in the damaged media, initially by cells nearest the
internal elastic lamina on day 2. Staining subse-
quently became diffuse throughout the media on
days 4 and 7 and was also localized to cells populat-
ing the early neointima on day 7 (Fig. 9). At day 28,
staining decreased in the neointima, whereas medial
and adventitial staining were at baseline.
DISCUSSION
We show in this study that angioplasty of arteries
with preexisting atherosclerosis created a transmural
injury or wound, and the subsequent healing
response involved all layers of the artery wall. A
highly regulated sequence of cellular and molecular
events ensued that in many ways was analogous to
wound healing. Thrombus provided a provisional
matrix at sites of injury for the influx of leukocytes
and a-actin–positive cells. Subsequently, a distinct
temporal and spatial pattern of extracellular matrix
elaboration resulted in the reorganization of the
thrombus into a proteoglycan-rich and hyaluronan-
rich neointima. As the neointima formed, fibrin and
vWF were trapped within the extracellular matrix.
Neointimal growth was complete 1 month after
injury, but the extracellular matrix matured further
with elastin fiber formation. Proteoglycan expression
was decreased at 4 months. Adventitial healing was
distinct from the neointima, as it occurred within
existing connective tissue. It was characterized by
fibrosis as adventitial fibroblasts continually
expressed collagen throughout the 4 months after
injury. Cell surface integrins appropriate for reorga-
nizing and contracting type-I collagen (a2b1) as well
as fibrin, vWF, and denatured collagen (avb3) were
also expressed transiently within the healing artery
Fig. 7. Composite photomicrograph of cross-sections stained for elastin (orcein stain) at days
14, 28, and 120. Elastin fibers within the healing neointima were not present until day 120
after injury. Original magnification, ´400.
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wall. This pattern of cellular ingrowth, matrix elabo-
ration, and integrin expression supports a wound
healing paradigm for artery wall contraction, result-
ing in lumen narrowing after reconstruction.
Wound healing and tissue contraction are rela-
tively new concepts in the pathogenesis of restenosis.
However, evidence is rapidly accumulating in sup-
port of the wall narrowing hypothesis. Intravascular
ultrasound imaging of atherosclerotic lesions and
sites of angioplasty has provided compelling evidence
that loss of artery wall size, or shrinkage, accounts for
60% to 80% of recurrent lumen narrowing.5 Further
evidence comes from stent studies. Stents provide a
rigid endoluminal scaffolding to prevent wall nar-
rowing so that stent restenosis comes entirely from
neointimal formation. Stents have reduced coronary
restenosis 15% to 30% by preventing wall narrowing
despite inducing more neointima than angioplasty
alone.30-32 As long-term sequelae of stents remain to
be defined, pharmacologic “stenting” of injured
arteries is a much more attractive approach for pre-
vention of restenosis but requires new molecular tar-
gets for intervention.
Wall narrowing after arterial injury could be a
result of passive “recoil” of a compliant wall and
perivascular tissue, to spasm, or to chronic tissue
contraction. Our previous studies in the monkey
model favor the last alternative, as wall and lumen
narrowing occur days or weeks after experimental
angioplasty.6 Recoil after clinical angioplasty is well
defined and acute, occurring within seconds to
hours of injury.33,34
We and others have speculated that late tissue
contraction within the healing artery wall may be
analogous to wound healing. In cutaneous wounds,
granulation tissue contracts to decrease wound size
and to facilitate reepithelialization.35 Granulation
tissue forms as leukocytes and fibroblasts migrate
into the provisional matrix provided by the fibrin
clot within the wound. Specialized fibroblasts, or
“myofibroblasts,” invade from the adjacent wound
edges, then replicate and elaborate new extracellular
matrix to rapidly replace the clot with new wound
granulation tissue.35 In the present study, intimal
and medial wounds were created by angioplasty and
were covered by a thin platelet-fibrin thrombus.
This provisional fibrin matrix was rapidly invaded by
leukocytes, SMCs, and possibly by myofibroblasts.
Myofibroblasts transiently express a-actin and con-
tract much like vascular SMCs.11
Recent studies have implicated myofibroblasts of
adventitial origin in neointima formation after arteri-
al injury.23,24 However, a lack of specific markers to
distinguish SMCs from myofibroblasts in healing
arteries prevents a clear understanding of the adven-
titial contribution to medial and intimal wound heal-
ing. In the present study, adventitial a-actin expres-
sion was not always seen even after deep medial
injury, and adventitial healing was clearly different
than medial and intimal healing. Changes within the
adventitia were more consistent with fibrosis (fibrob-
last collagen synthesis), whereas SMCs and matrix
rich in hyaluronan and versican predominated at sites
of medial and intimal repair. Although adventitial
Fig. 8. Composite photomicrograph of cross-section of
uninjured (A) and injured (B) iliac artery 28 days after
experimental angioplasty. a2 integrin staining (arrows)
was seen only in the injured artery within the neointima
(arrowheads) nearest the lumen. Original magnification,
´400.
Fig. 9. Composite photomicrograph of cross-section of
uninjured (A) and injured (B) iliac artery 7 days after
experimental angioplasty. avb3 integrin staining was seen
in the preexisting atherosclerotic plaque of uninjured iliac
arteries near regions of mineralization (arrows), whereas
staining increased after injury in the media (arrowheads)
and in the earliest-forming neointima near the lumen
(arrow). Original magnification, ´400.
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fibrosis has been underemphasized in experimental
studies, the vascular surgeon recognizes its sequelae
when dissecting the dense connective tissue that sur-
rounds artery segments previously treated by angio-
plasty. The extent of adventitial fibrosis may signifi-
cantly alter remodeling of the healing artery wall and
contribute to wall constriction.
Wound contraction is mediated by myofibrob-
last–extracellular matrix interactions. Cell surface
integrins are highly selective receptors for specific
matrix molecules, and the pattern of integrins
expressed in wounds is unique.12-14,35 Cultured
fibroblasts and SMCs have altered integrin expres-
sion and use identical integrins for migration and for
specific matrix lattice reorganization. The b1 inte-
grins are critical for migration and contraction on
collagen matrixes, as blocking antibodies specific for
a2b1 will prevent both functions in culture.12,27,28,36
Similarly, blocking antibodies specific for the avb3
integrin prevent migration and contraction in fibrin
gels.13,37 In the present study, these integrins and
appropriate extracellular matrix ligands were
expressed within the injured artery wall in a tempo-
ral pattern consistent with the time course of wall
contraction defined in our previous studies.6
Although we limited our analysis to the a2b1 and
avb3 integrins, other matrix receptors have also been
implicated in the arterial response to injury.27,38
Further evidence for the role of integrins in the
arterial healing response comes from in vivo studies
in animals and man. Until recently, virtually all
antirestenosis therapies have failed in large multicen-
ter clinical trials. It is intriguing that the only drug
that is effective in preventing early and late compli-
cations after coronary angioplasty, ReoPro, is a b3
integrin antagonist.39,40 ReoPro is a human
chimeric Fab fragment of a monoclonal antibody
developed to inhibit the platelet IIb/IIIa integrin
receptor, which mediates platelet aggregation and
adhesion. ReoPro also binds the SMC avb3 integrin
with equal affinity. This observation and the long-
term reduction of death, myocardial infarction, and
target vessel revascularization after angioplasty has
led to speculation that ReoPro may be acting direct-
ly on the artery wall. Other SMC b3 integrin antag-
onists have also been effective at inhibiting intimal
hyperplasia in animal models.41,42 However, effects
on artery wall contraction and lumen narrowing
have not been reported. Our finding of increased
expression of contractile integrins along with their
specific matrix ligands within the healing media and
intima further support targeting of integrins for
pharmacologic “stenting” of the injured artery wall.
The abundance of versican and hyaluronan with-
in the healing intima is consistent with new tissue
formation because both are important components
of healing wounds.25,26 Hyaluronan is a large
hydrophilic polymer of repeating disaccharides com-
monly associated with tissue formation in embryo-
genesis, wound healing, and neoplasia.26,43,44
Although a role is not completely defined, hyaluro-
nan appears to provide hydrated space favorable for
cell movement, invasion, and replication. Versican
binds along the hyaluronan backbone to provide an
ordered matrix that can function to restore a tissue’s
viscoelasticity. Hyaluronan has recently been shown
to be prominent in the injured rat carotid artery,19
but present transiently when compared with injured
atherosclerotic monkey arteries. The presence of
hyaluronan at day 120 in the present study is similar
to that seen in atherectomy tissues retrieved from
restenotic human coronary arteries, where hyaluro-
nan is variably present at late times after angioplas-
ty.19 The ratio of hyaluronan and associated proteo-
glycans to structural matrix proteins (collagen and
elastin) can alter the contraction of these lattices in
culture. Similar interactions within the healing
artery wall may influence the degree of contraction
and restenosis.
The present study has largely focused on early
structural events after angioplasty, but we recognize
that healing may continue to change the structure of
the injured artery wall for many months. For
instance, we documented a change in the composi-
tion of the neointima between day 28 and day 120
after angioplasty with loss of versican and the
appearance of new elastic fibers. In human beings,
lumen narrowing is frequent at later times (3 to 9
months after angioplasty), supporting a role for
chronic tissue contraction in restenosis.31 This is still
consistent with a wound healing mechanism. As
granulation tissue is replaced by scar, a variable
extent of fibrosis and remodeling continues for
many months.35 Fibrosis and tissue contraction dur-
ing late scar maturation can be extensive and disfig-
uring. Variability in late fibrosis and remodeling
within the artery wall could affect lumen narrowing
months after an intervention.
CONCLUSION
A highly regulated pattern of cellular and molec-
ular events occurs in response to injury of atheroscle-
rotic arteries in nonhuman primates that are in many
ways analogous to wound healing. Distinct differ-
ences in healing were noted in the adventitia com-
pared with the intima and media, and adventitial
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fibrosis is prominent after injury. The elaboration of
specific matrix molecules and their cell surface inte-
grin-receptors supports the concept of integrin-
mediated matrix reorganization by SMCs and myofi-
broblasts. The degree of extracellular matrix reorga-
nization could greatly influence wall contraction after
injury and thereby lumen narrowing. Although these
descriptive observations lend support to a wound
healing hypothesis for restenosis, only carefully
designed blocking experiments can prove its rele-
vance. As specific blocking reagents have become
available these studies are now possible, and pharma-
cologic strategies to inhibit tissue contraction may
soon help to improve outcomes of vascular recon-
structions.
We thank Ms. Deanna Brown for her expert assistance
with immunohistochemical analysis and in situ hybridiza-
tion and Ms. Michelle Gammons for preparing the manu-
script.
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DISCUSSION
Dr. Howard P. Greisler (Maywood, Ill.). This is
important work, this is an important model, and those are
obviously beautiful pictures. I would like to congratulate
Dr. Geary and his coworkers for their refreshing lucidity
and for the innovative but logical approach that they’re
using in developing and characterizing what I think is an
important animal model of peripheral artery restenosis
after balloon angioplasty. I highly recommend that this
manuscript be widely read. But like most good science,
these studies do provide some answers, but I think they
are far more important for the questions that they raise.
In broad terms, restenosis may reflect a number of
things: elastic recoil, which is probably important primar-
ily in the coronary circulation; myointimal hyperplasia;
and tissue modeling and contraction. The authors have
started with the clinical observation that late human coro-
nary restenosis after angioplasty plus stent deployment
probably results in as much as a 15% to 20% decrease in
restenosis as compared with balloon angioplasty alone,
despite the fact that the presence of the stent induces an
increase in neointimal hyperplasia. So the only logical
explanation of this effect is that the stent has an impact on
late remodeling and perhaps wound contraction.
The major strengths of this work today are the
detailed histopathologic analyses of the responses to arte-
rial wall injury in this very unique model, the emphasis on
the role of matrix remodeling and contraction, and prob-
ably most important, the appropriate refocusing of our
thinking of these responses using the paradigm of wound
healing. This leads to my three questions for the author.
In short form first, which mechanical aspect of the
injury induces wound contraction? Which part of the arter-
ial wall contracts? And what are the cell types and signaling
processes that link the injury to the remodeling response?
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As for the first question, the angioplasty model that is
used creates a very complex injury involving intimal
denudation, presumably medial cell necrosis and intra-
mural inflammation, arterial wall and periadventitial
stretch, arterial wall compression, and full thickness tears
of the media. Have the authors used lesser injuries, for
example, injuries with and without the component of
overdistention to begin to discriminate between responses
to different components of the injury? This may seem a lit-
tle picky, but I think it’s very important because we all
know the complexity and lack of uniformity of the lesions
that we deal with clinically, and so most likely angioplasty
of clinical lesions has relatively different amounts of these
different injury components.
Second, in this model which of the layers of the arter-
ial wall showed contraction by morphometry? Was this
pattern consistent? Considering the importance of the
adventitia in the pathogenesis of neointimal hyperplasia in
some models of stretch injury, do the authors believe that
adventitial remodeling is of great pathophysiologic rele-
vance in this model?
The morphometric data presented were somewhat
surprising to me in that it suggested that there was no dif-
ference in neointimal area when comparing 28-day and
120-day explants. In our laboratory we use a canine angio-
plasty model, and we find a peak in neointimal thickness at
1 month, which significantly decreases at 3 months, pre-
sumably from tissue remodeling. How do the authors
explain these differences in results?
Third, the authors have shown an early expression in
the forming neointima of both avb3 and a2b1 integrins,
suggesting their potential role in mediating wound con-
traction and remodeling. But remodeling occurs at late
time points. Do the authors have data that show a tempo-
ral and a spatial correlation between wound contraction
and the expression of these contractile integrins? Recently,
there has been clinical use of a b3 integrin subunit
inhibitor, which has shown a decrease in intimal hyperpla-
sia in animal models and also a decrease in clinical
post–coronary angioplasty myocardial infarction, possibly
related to avb3 blockade and subsequent effects either on
remodeling or on vitronectin-facilitated SMC migration.
Have the authors evaluated the effect of this agent on
either intimal thickening or on arterial wall contraction in
this model? In other words, how do you get at the issue of
causality between the expression of these contractile inte-
grins and later wound contraction?
Finally, it must be pointed out that although these
studies suggest the importance of remodeling in resteno-
sis after balloon angioplasty, restenosis also occurs after
endarterectomy, vein graft and synthetic bypass grafting,
and stent deployment, all techniques likely less affected by
tissue remodeling.
Again, despite these questions, or perhaps because these
studies have provoked these questions, I do want to strongly
acknowledge the creativity of this work and the innovation of
the analyses, and I commend it to the audience for reading.
Dr. Randolph L. Geary. Thank you, Dr. Greisler, for
those kind and insightful comments and questions. You
point out that various types of injury may invoke different
responses within the injured artery wall, and this is cer-
tainly true. We use a Fogarty balloon catheter rather than
a standard angioplasty catheter, and we do a three-pass
withdrawal injury. As you alluded to, this likely causes
shear injury and more denudation than a standard
Gruentzig catheter.
We settled on this mode of injury after experimenting
with Gruentzig catheters injury in the monkey model. The
problem with the Gruentzig catheter is that these arteries
are very small and each lumen is a different caliber, where-
as Gruentzig catheters come only in fixed diameters. Also,
atherosclerotic lesions vary from monkey to monkey just
as in man and often are eccentric, so that a fixed dilation
may only stretch the more normal artery wall. These fac-
tors contribute to variability in the injury. With a Fogarty
catheter, although we cause a more severe injury, it tends
to be more consistent from artery to artery, albeit a maxi-
mal injury every time.
If you compare our histologic findings with the
human situation, as previously shown by Dr. Zarins and
more recently in studies with intravascular ultrasound, the
fractures and dissections that we create with the Fogarty
catheter are very similar to the clinical situation. We have
proven, at least in our hands, that the Fogarty catheter
injury does not remove any of the preexisting lesion. We
have studied that very carefully. But we cannot, as you
point out, rule out other effects such as the longitudinal
shear that is induced by withdrawing a balloon catheter
under tension. So there could be mechanical aspects to
this model that differ from the clinical situation.
In terms of which layer of the healing artery wall is
contracting, I would be very appreciative of any sugges-
tions about how to sort that out. The artery wall size
changes, and we can measure that by tracing the external
elastic lamina or the internal elastic lamina, but we cannot
quantitate the contribution of each individual wall layer.
For instance, medial size and preexisting plaque size do
not change after angioplasty despite a decrease in artery
wall size. The neointima adds to intimal mass, and
although we can measure its size, we have no way of
assessing its contraction over time.
The adventitia is even more difficult to quantify if you
included it in measures of artery wall size because it blends
into the surrounding connective tissue and has no clear
outer boundary. To complicate this issue further, when a
medial fracture occurs, which happens frequently, it is
overlying the fracture site that the adventitia is most
involved in the injury process. So thickening and fibrosis
are not circumferential in every case. Your question raises
a critical issue, but this is something that we just have not
been able to get our hands around.
If you consider surgical procedures on arteries that
have previously undergone angioplasty, you encounter a
dense adventitial fibrosis around the artery that destroys
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the plane of dissection that is normally present between
the artery wall and surrounding tissues. I believe that this
adventitial fibrosis plays a critical role in preventing the
artery from enlarging to accommodate neointimal growth
and may account for constriction of the artery wall analo-
gous to wound contraction. The neointima may also con-
tract over time as the composition of cells, extracellular
matrix, and integrins could allow for “wound contrac-
tion.” I didn’t address this today, but our previous studies
have shown that a degree of wall contraction actually
occurs early, before the neointima is well formed, at 7 and
14 days. This supports an adventitial or medial process.
As far as intimal hypoplasia regressing at late times after
injury, we have studied about 48 animals at the 4-month
time point. Some of those were control animals, and some
were involved in treatment protocols with estrogen, trying
to prevent intimal hyperplasia. In general, the ratio of the
neointima to the preexisting plaque did not differ signifi-
cantly from what we have reported at 1 month. I don’t
know why, but as you point out, in models of normal arte-
rial injury the neointima usually regresses over time. I sus-
pect that this has to do with shear stress and related
changes in artery wall diameter. Shear and other factors
that lead to neointimal regression may be overcome by the
effects of preexisting atherosclerosis, as in our model.
You point out that the mechanism of restenosis is not
the same for stented arteries and prosthetic grafts, where
intimal hyperplasia is clearly the problem. What we are
attempting to model is injury as it occurs with angioplas-
ty, endarterectomy, and perhaps atherectomy.
Lastly, you commented on the clinical studies that
demonstrated improved results after coronary angioplasty
in patients treated with ReoPro. We are studying ReoPro
in the monkey model. ReoPro is a b3 integrin antagonist
and inhibits platelet function by blocking the platelet gly-
coprotein IIb/IIIa integrin receptor. It has an equal affin-
ity for artery wall b3 integrins, which has led to specula-
tion that improved clinical results with ReoPro may be a
result of an artery wall effect in addition to, or instead of,
a platelet effect. Our data are just now being compiled,
and I really don’t have a clear answer yet whether ReoPro
will work in the monkey model.
Dr. Alexander W. Clowes (Seattle, Wash.). I have
just a very brief question. These are beautiful studies. We
know that in small animals the healing is conducted large-
ly by the smooth muscle cells derived from the media, yet
in these complex wounds there are many sources of a-
actin–positive cells. What is doing the healing?
Dr. Geary. That’s a very good question. Dr. Wilcox at
Emory has suggested that myofibroblasts, which express
a-actin, are as important in repopulating the injured
artery wall as smooth muscle cells. They performed pulse-
labeling experiments in which they administered BrdU to
label proliferating cells within the first day or two after
injury and found most labeled cells in the adventitia.
When they looked at later time points, labeled cells had
migrated into the neointima. So adventitial fibroblasts can
contribute to the neointima. Dr. Zalewski’s group in
Philadelphia has published similar data in the pig angio-
plasty model, suggesting that adventitial fibroblasts differ-
entiate into myofibroblasts, which, if you fracture the
artery wall, participate in intimal hyperplasia. In the ather-
osclerotic monkey model it is less clear. We don’t see a dis-
tinct wave of a-actin expression within the adventitia as
described by other groups. We do see it occasionally, but
it’s far less consistent. It appears that the healing process
that forms the neointima is different than the process we
see in the adventitia. I will speculate that myofibroblasts
are contributing more to the fibrotic response in the
adventitia. We know that in culture and in models of
wound healing that fibroblasts are better producers of col-
lagen and other structural matrix molecules than smooth
muscle cells, whereas in the intima it’s probably predomi-
nantly a smooth muscle cell process.
